Category Health Policy Watch

USTR IP Report Sparks Outcry Among Health Advocates

The annual Special 301 report of the Office of the United States Trade Representative (USTR) issued today sparked a quick outcry among health advocates over its seemingly more restrictive approach they say bullies other countries into unfairly promoting US pharmaceutical industry rights to an extent that would raise drug prices and limit accessibility.

USTR Annual Special 301 Report Intensifies Action On China, Colombia, Canada

The annual report of the Office of the United States Trade Representative (USTR) on the adequacy of trading partners’ protection of US intellectual property rights celebrated its 30th year this year with a sharper tone with China, in keeping with the Trump administration’s tough stance on the country. Also caught in the report are Colombia and Canada, which were downgraded to the “priority watch list.” Also, this year the report includes a special highlight on pharmaceuticals and medical devices.

Carlos Correa Named Head Of Intergovernmental South Centre

Prof. Carlos Correa of Argentina, an influential academic whose analyses of patents and medicines access have informed debates and challenged the status quo for decades, has been named the next executive director of the South Centre. He will take over for Martin Khor, who will be retiring after nine years at the helm. Separately, former South African President Thabo Mbeki was named chair of the Board.

Dozens Of NGOs Oppose Proposed EU Watch List On IP Rights

A wide-ranging list of international nongovernmental organisations today issued a letter to European Trade Commissioner Cecilia Malmström opposing a proposal to establish a "watch list" of countries deemed failing to protect European intellectual property. The groups raised concern that the list would violate World Trade Organization rules on intellectual property, have a chilling effect on developing countries' public health initiatives, and lead to expanded and untenable levels of IP enforcement.

Fairness In Research Partnerships, Reporting System Presented At Geneva Health Forum

Research collaborations between institutions in the North and institutions in the South often show a scientific and power imbalance. In the context of growing concerns about this issue, initiatives are being developed to increase fairness in research partnerships. In particular, the Research Fairness Initiative, providing a reporting system for institutions is gaining traction, according to speakers at the Geneva Health Forum this week.

Study: Global Consumption Of Antibiotics Rising, In Particular In LMICs; Policy Change Needed

In the face of the growing threat of antimicrobial resistance, a recent study of the Proceedings of the National Academy of Sciences of the United States of America (PNSA) found that the antibiotic consumption rate in low and middle-income countries has substantially increased in recent years. At the same time, inequities in drug access persist in many countries, with high rates of infectious disease-related mortality, according to the study.

At Geneva Health Forum: Importance Of High Quality Of Health Systems, Beyond Access

Achieving a high percentage of universal health coverage often does not translate into a high quality of health systems, according to speakers at the opening of the Geneva Health Forum. While in developed countries people are demanding better quality, the expectations of people living in low and middle-income countries need to be raised, they said. Another panel looked at the use of big data and mathematical modelling as ways to improve health systems, including Facebook monitoring.

Taiwan IP Office Moves Beyond Politics To Forge Links With Other IP Offices, Enforce IP Rights

TAIPEI, Taiwan -- The building is impressive. Taiwan’s intellectual property office, located in the Dan-an district of Taipei, deals with patents, trademarks, designs, and utility models. Not being a recognised member of the United Nations, Taiwan cannot access the World Intellectual Property Organization treaties, in particular the Patent Cooperation Treaty. However, Taiwan is dedicated to enforcing IP rights, and entertains agreements with several IP offices in the world, including China, which is Taiwan's major trading partner.